Skip to the page

Data / Form D filings / Double Blind Bio Inc.

Double Blind Bio Inc.: Form D filing

Double Blind Bio Inc., a technology company in San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on December 29, 2025, reports $5.6 million sold of a $5.6 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
187 16TH AVENUE, San Francisco, CA, 94118
Phone
(650) 353-8858
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2102510

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 29, 2025New notice$5,619,999$5,619,9996Dec 10, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David HughesExecutive Officer, Director
Shruti TibrewalaExecutive Officer, Director

Other technology companies in California that filed recently

Every Form D from the week of Dec 29, 2025 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Double Blind Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.